1004 results
Therapeutic Advantages and Disadvantages of some NSAIDs
Salicylates: Aspirin, Salicylate salts, Diflunisal
Acetic acids: Indomethacin, Sulindac, Tolmetin
Propionic acids:
Diflunisal Acetic acids ... Tolmetin Propionic acids ... Fenamates: Mefenamic acid ... , Meclofenamic acid ... Disadvantages #comparison
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Insulin Lifestyle modifications ... medications #table #comparison
Lifestyle Therapy for Diabetes - AACE 2018 Guidelines

#Lifestyle #Modifications #Therapy #Diabetes #DM2 #AACE #2018 #Guidelines #Management
#Lifestyle #Modifications
Pathways Involved in Protein and Amino Acid Metabolism in Chronic Kidney Disease. The tricarboxylic acid (TCA)
Protein and Amino Acid ... tricarboxylic acid ... metabolize amino acids ... products of amino acid ... oxidation of amino acids
Diuretic Electrolyte Excretion Effects 
Diuresis, Na+, K+, Mg2+, Ca2+, Cl-, HCO3-, Uric Acid
 - Thiazide Type
-, HCO3-, Uric Acid ... #pharmacology #comparison
Crystalluria Guide - Various Crystals on Urine Microscopy 
 - Triple Phosphate
 - Uric Acid
 -
Phosphate - Uric Acid ... Urine #Microscopy #comparison
Hyperuricemia: Pathogenesis and Complications

 - Hypercalcemia (due to diseases like Sarcoidosis and Hyperparathyroidism) -> Accumulation of
to filter uric acid ... diuretics, organic acids ... like lactic acid ... and keto-acids) ... secretion of uric acid
Bile acids are the end products of cholesterol catabolism. Cholic acid and chenodeoxycholic acid are the
Bile acids are the ... Cholic acid and ... chenodeoxycholic acid ... major primary bile acids ... to 600 mg bile acids
Main types of autoimmune encephalitis in the ICU. 
Anti-NMDAR anti-N-methyl-d-aspartate receptor, ADEM acute disseminated encephalomyelitis, Anti-GFAP
anti-gamma aminobutyric acid ... anti-gamma aminobutyric acid ... isoxazolepropionic acid ... #encephalitis #comparison
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
DMARDs - Treatment Modification